These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10454298)

  • 1. Spatial features in body surface potential maps of patients with ventricular tachyarrhythmias with or without coronary artery disease.
    Stellbrink C; Mischke K; Stegemann E; Killmann R; Minkenberg R; Lü XY; Schütt H; Hanrath P
    Int J Cardiol; 1999 Jul; 70(2):109-18. PubMed ID: 10454298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic identification of abnormal ventricular depolarization and repolarization in patients with idiopathic ventricular fibrillation.
    Peeters HA; Sippensgroenewegen A; Wever EF; Potse M; Daniëls MC; Grimbergen CA; Hauer RN; Robles de Medina EO
    J Am Coll Cardiol; 1998 May; 31(6):1406-13. PubMed ID: 9581742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of QRST integral and QT dispersion by body surface potential mapping in patients with malignant ventricular arrhythmias].
    Stellbrink C; Stegemann E; Killmann R; Mischke K; Schütt H; Hanrath P
    Herzschrittmacherther Elektrophysiol; 1997 Jun; 8(2):107-12. PubMed ID: 19484521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of magnetocardiographic QRST integral maps in the identification of patients at risk of ventricular arrhythmias.
    Hren R; Steinhoff U; Gessner C; Endt P; Goedde P; Agrawal R; Oeff M; Lux RL; Trahms L
    Pacing Clin Electrophysiol; 1999 Sep; 22(9):1292-304. PubMed ID: 10527010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmia vulnerability assessment using magnetic field maps and body surface potential maps.
    Stroink G; Meeder RJ; Elliott P; Lant J; Gardner MJ
    Pacing Clin Electrophysiol; 1999 Dec; 22(12):1718-28. PubMed ID: 10642124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-hospital body surface potential mapping improves early diagnosis of acute coronary artery occlusion in patients with ventricular fibrillation and cardiac arrest.
    Daly MJ; Finlay DD; Scott PJ; Nugent CD; Adgey AA; Harbinson MT
    Resuscitation; 2013 Jan; 84(1):37-41. PubMed ID: 22986067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate variability and dispersion of QT interval in patients with vulnerability to ventricular tachycardia and ventricular fibrillation after previous myocardial infarction.
    Perkiömäki JS; Huikuri HV; Koistinen JM; Mäkikallio T; Castellanos A; Myerburg RJ
    J Am Coll Cardiol; 1997 Nov; 30(5):1331-8. PubMed ID: 9350936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the QT interval and its adaptation to rate, assessed with continuous electrocardiographic recordings in patients with ventricular fibrillation, as compared to normal individuals without arrhythmias.
    Tavernier R; Jordaens L; Haerynck F; Derycke E; Clement DL
    Eur Heart J; 1997 Jun; 18(6):994-9. PubMed ID: 9183592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical QRST integral changes with ventricular repolarization dispersion.
    Okazaki O; Lux RL
    J Electrocardiol; 1999; 32 Suppl():60-9. PubMed ID: 10688304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery time dispersion measured from 87-lead body surface potential mapping as a predictor of sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy.
    Aiba T; Inagaki M; Shimizu W; Matsuo K; Taguchi A; Suyama K; Kurita T; Aihara N; Sunagawa K; Kamakura S
    J Cardiovasc Electrophysiol; 2000 Sep; 11(9):968-74. PubMed ID: 11021466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial features in body-surface potential maps can identify patients with a history of sustained ventricular tachycardia.
    Hubley-Kozey CL; Mitchell LB; Gardner MJ; Warren JW; Penney CJ; Smith ER; Horácek BM
    Circulation; 1995 Oct; 92(7):1825-38. PubMed ID: 7671367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of body surface potential field representation fidelity: analysis of beat-to-beat repolarization measurements.
    Kozmann G; Haraszti K
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():5-7. PubMed ID: 17584667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic measures of ventricular repolarisation dispersion in patients with coronary artery disease susceptible to ventricular fibrillation.
    Oikarinen L; Toivonen L; Viitasalo M
    Heart; 1998 Jun; 79(6):554-9. PubMed ID: 10078081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of amiodarone on QT dispersion in patients with life-threatening ventricular arrhythmias and clinical outcome.
    Meierhenrich R; Helguera ME; Kidwell GA; Tebbe U
    Int J Cardiol; 1997 Aug; 60(3):289-94. PubMed ID: 9261640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT dispersion failed to estimate the global dispersion of ventricular repolarization measured using monophasic action potential mapping technique in swine and patients.
    Liang Y; Kongstad O; Luo J; Liao Q; Holm M; Olsson B; Yuan S
    J Electrocardiol; 2005 Jan; 38(1):19-27. PubMed ID: 15660343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic drug effects on QT interval dispersion in patients undergoing electropharmacologic testing for ventricular tachycardia and fibrillation.
    Gillis AM; Traboulsi M; Hii JT; Wyse DG; Duff HJ; McDonald M; Mitchell LB
    Am J Cardiol; 1998 Mar; 81(5):588-93. PubMed ID: 9514455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is idiopathic ventricular fibrillation a short QT syndrome? Comparison of QT intervals of patients with idiopathic ventricular fibrillation and healthy controls.
    Viskin S; Zeltser D; Ish-Shalom M; Katz A; Glikson M; Justo D; Tekes-Manova D; Belhassen B
    Heart Rhythm; 2004 Nov; 1(5):587-91. PubMed ID: 15851224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body-surface QRST integral mapping. Arrhythmogenic righ ventricular dysplasia versus idiopathic right ventricular tachycardia.
    Peeters HA; SippensGroenewegen A; Schoonderwoerd BA; Wever EF; Grimbergen CA; Hauer RN; Rohles de Medina EO
    Circulation; 1997 Jun; 95(12):2668-76. PubMed ID: 9193436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal variation of QT dispersion in patients with and without coronary artery disease.
    Yetkin E; Senen K; Ileri M; Atak R; Topaloğlu S; Ergün K; Yanik A; Tandoğan I; Cehreli S; Duru E; Demirkan D
    Angiology; 2001 May; 52(5):311-6. PubMed ID: 11386381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of postmyocardial infarction scar size, cardiac function, and severity of coronary artery disease on QT interval dispersion as a risk factor for complex ventricular arrhythmia.
    Puljevic D; Smalcelj A; Durakovic Z; Goldner V
    Pacing Clin Electrophysiol; 1998 Aug; 21(8):1508-16. PubMed ID: 9725148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.